FORVIA CONFIRMS THE SUCCESSFUL PROGRESS OF ITS ASSET DISPOSAL PROGRAM WITH THE ENTRY OF STELLANTIS IN SYMBIO'S CAPITAL
16. Mai 2023 02:10 ET
|
FAURECIA
NANTERRE (FRANCE)MAY 16, 2023 FORVIA CONFIRMS THE SUCCESSFUL PROGRESS OF ITS ASSET DISPOSAL PROGRAM WITH THE ENTRY OF STELLANTIS IN SYMBIO'S CAPITAL With the acquisition by STELLANTIS of a stake in...
FORVIA CONFIRME LE BON DÉROULEMENT DE SON PROGRAMME DE CESSIONS D’ACTIFS AVEC L'ENTRÉE DE STELLANTIS AU CAPITAL DE SYMBIO
16. Mai 2023 02:10 ET
|
FAURECIA
NANTERRE (FRANCE)16 MAI 2023 FORVIA CONFIRME LE BON DÉROULEMENT DE SON PROGRAMME DE CESSIONS D’ACTIFS AVEC L'ENTRÉE DE STELLANTIS AU CAPITAL DE SYMBIO Avec l'acquisition par STELLANTIS d'une...
Initiation of Phase 3 Clinical Trial on the Patient-controlled Pain Management Drug "SyB P-1501"
13. Juni 2016 01:18 ET
|
SymBio Pharmaceuticals Ltd
TOKYO, June 13, 2016 (GLOBE NEWSWIRE) -- SymBio Pharmaceuticals Limited (Headquarters: Tokyo, “SymBio”) announced today that the Phase 3 clinical trial on “SyB P-1501” – a drug for...
Jacob Hsu of the Symbio Group Joins Global Leaders to Speak at the World Economic Forum in Tianjin, China
26. September 2008 13:56 ET
|
Symbio Group
ROCKVILLE, MD and BEIJING--(Marketwire - September 26, 2008) - Jacob Hsu, CEO of the Symbio
Group (www.symbio-group.com), will be speaking on "Picking the Perfect
Board: Mission Impossible?" at the...
Symbio Named Top 10 China Offshore Software Development Vendor by IDC
23. Juni 2008 10:07 ET
|
Symbio Group
ROCKVILLE, MD and BEIJING--(Marketwire - June 23, 2008) - The Symbio Group
(www.symbio-group.com) today announced that it was named one of the top 10
Offshore Software Development Outsourcing Vendors...